When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 17 Hits
  • Search Condition : Filter (MeSH = Colonic Neoplasms / immunology)
Species Resource Title
Human and Animal Cells RCN-9(RCB0511) In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
Human and Animal Cells Colon-26(RCB2657) Therapy of peritoneally disseminated colon cancer by TAP-deficient embryonic stem cell-derived macrophages in allogeneic recipients.
Human and Animal Cells Colon-26(RCB2657) Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response.
Human and Animal Cells Colon-26(RCB2657) Tumour-associated macrophages targeted transfection with NF-κB decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice.
Human and Animal Cells T2(RCB1932) Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
Human and Animal Cells THP-1(RCB1189) Virus-Like Particles Displaying Recombinant Short-Chain Fragment Region and Interleukin 2 for Targeting Colon Cancer Tumors and Attracting Macrophages.
Human and Animal Cells MKN45(RCB1001) , K562(RCB0027) , DAUDI(RCB1640) In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells.
Human and Animal Cells Colon-26(RCB2657) Cancer therapy with major histocompatibility complex-deficient and interferon β-producing myeloid cells derived from allogeneic embryonic stem cells.
Human and Animal Cells LLC(RCB0558) Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation.
Human and Animal Cells Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.
Human and Animal Cells TGBC2TKB(RCB1130) Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
Human and Animal Cells CHO Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.
Human and Animal Cells Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
Human and Animal Cells CACO-2(RCB0988) Isolation and characterization of a novel short peptide associated with Crohn's disease.
Human and Animal Cells Hep G2(RCB0459) , RCN-9(RCB0511) Immunogene therapy against colon cancer metastasis using an adenovirus vector expressing CD40 ligand.
DNA material AxCAmIL12p40 Adex1CAmIL12p40 (RDB1417) AxCAmIL12p35 Adex1CAmIL12p35 (RDB1414) Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Human and Animal Cells LC-1/sq(RCB0455) Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses.